Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies


Our achievements would not be possible without the outstanding team that make up Shield Therapeutics’ staff, management and board of directors.

President Shield US and Chief Commercial Officer

Brian Groch

Brian leads our US organisation and global commercial strategy.  He brings to Shield over 30 years of highly relevant and successful experience of building high-performing teams and launching and commercialising around 30 pharmaceutical products in both Big Pharma and biotech companies. Over the last 11 years he has gained deep expertise in start-up and scaled growth stage companies and has supported the raising over $100 million.  Most recently, he served as Executive Vice President and Chief Commercial Officer at Acasti Pharma.  Prior to Acasti, he was the Executive Vice President and Chief Commercial Officer at Veru, Inc., a urology, oncology, and female health products company. He also served as Chief Commercial Officer for Telesta Therapeutics, where he led the development and implementation of the global commercial strategy for the first oncology product for bladder cancer in 25 years. Previously, he served as Vice President of Commercial Operations and Market Access for Horizon Therapeutics, as CEO and President of Exsto Therapeutics and Head of Market Access at Dendreon. He has held management roles with Novartis and Merck & Co. He earned his master’s degree in Marketing from Central Michigan University, as well as a B.S. in Physiology from Central Michigan University.

Back to team